Ameliorative effects of a neuroprotective agent, T-817MA, on place learning deficits induced by continuous infusion of amyloid-β peptide (1-40) in rats

Hippocampus

Volumn 17, Issue 6, 2007, Pages 443-455

  Nguyen, Phuong Thi Hong ^a,b   Kimura, Tatsuo ^a,b   Son, Anh Ho ^a,b   Anh, Hai Tran ^a,b   Ono, Taketoshi ^a,b   Nishijo, Hisao ^a,b  

^a UNIVERSITY OF TOYAMA   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Alzheimer's disease; Dementia; Dentate gyrus; Hippocampus; Memory

Indexed keywords

1 [3 [2 (1 BENZOTHIOPHEN 5 YL)ETHOXY]PROPYL] 3 AZETIDINOL MALEATE; AMYLOID BETA PROTEIN[1-40]; CHOLINESTERASE INHIBITOR; DONEPEZIL; NEUROPROTECTIVE AGENT; T 817MA; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COGNITIVE DEFECT; CONTINUOUS INFUSION; CONTROLLED STUDY; DEGENERATIVE DISEASE; DENTATE GYRUS; LEARNING DISORDER; MALE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OSMOTIC PUMP; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; TASK PERFORMANCE;

AMYLOID BETA-PROTEIN; ANIMALS; BECLOMETHASONE; BEHAVIOR, ANIMAL; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; HIPPOCAMPUS; LEARNING DISORDERS; MALE; MALEATES; MOVEMENT; NEUROPROTECTIVE AGENTS; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; SELF ADMINISTRATION; THIOPHENES; TIME FACTORS;

EID: 34250157687     PISSN: 10509631     EISSN: 10981063     Source Type: Journal    
DOI: 10.1002/hipo.20281     Document Type: Article

References (76)

1. Aberg MA, Aberg ND, Hedbacker H, Oscarsson J, Eriksson PS. 2000. Peripheral infusion of IGF-1 selectively induces neurogenesis in the adult rat hippocampus. J Neurosci 20:2896-2903.
2. Akasofu S, Kosasa T, Kimura M, Kubota A. 2003. Protective effect of donepezil in a primary culture of rat cortical neurons exposed to oxygen-glucose deprivation. Eur J Pharmacol 472:57-63.
3. Akasofu S, Kimura M, Kosasa T, Ogura H, Sawada K. 2006. Protective effect of donepezil in primary-cultured rat cortical neurons exposed to N-methyl-D-aspartate (NMDA) toxicity. Eur J Pharmacol 530:215-222.
4. Barnes CA, McNaughton BL. 1985. An age comparison of the rates of acquisition and forgetting of spatial information in relation to long-term enhancement of hippocampal synapses. Behav Neurosci 99:1040-1048.
5. Bayer TA, Wirths O, Majtenyi K, Hartmann T, Multhaup G, Beyreuther K, Czech C. 2001. Key factors in Alzheimer's disease: β-Amyloid precursor protein processing, metabolism and intraneuronal transport. Brain Pathol 11:1-11.
6. Behl C. 1997. Amyloid β-protein toxicity and oxidative stress in Alzheimer's disease. Cell Tissue Res 290:471-480.
7. Block F, Pergande G, Schwarz M. 1997. Flupirtine reduces functional deficits and neuronal damage after global ischemia in rats. Brain Res 754:279-284.
8. Carr DB, Goate A, Phild D, Morris JC. 1997. Current concepts in the pathogenesis of Alzheimer's disease. Am J Med 103:3S-10S.
9. Chin J, Palop JJ, Puoliväli J, Massaro C, Bien-Ly N, Gerstein H, Scearce-Levie K, Masliah E, Mucke L. 2005. Fyn kinase induces synaptic and cognitive impairments in a transgenic mouse model of Alzheimer's disease. J Neurosci 25:9694-9703.
10. Csernansky JG, Martin M, Shah R, Bertchume A, Colvin J, Dong H. 2005. Cholinesterase inhibitors ameliorate behavioral deficits induced by MK-801 in mice. Neuropsychopharmacology 30:2135-2143.
11. Dong H, Csernansky CA, Martin MV, Bertchume A, Vallera D, Csernansky JG. 2005. Acetylcholinesterase inhibitors ameliorate behavioral deficits in the Tg2576 mouse model of Alzheimer's disease. Psychopharmacology 181:145-152.
12. Fukuda M, Kobayashi T, Bures J, Ono T. 1992. Rat exploratory behavior controlled by intracranial self-stimulation improves the study of place cell activity. J Neurosci Methods 44:121-131.
13. Gilbert PE, Kesner RP, Lee I. 2001. Dissociating hippocampal subregions: A double dissociation between dentate gyrus and CA1. Hippocampus 11:626-636.
14. Hirata K, Yamaguchi H, Takamura Y, Takagi A, Fukushima T, Iwakami N, Saitoh A, Nakagawa M, Yamada T. 2005. A novel neurotrophic agent, T-817MA [1-{3-[2-(1-benzothiophen-5-yl) ethoxy] propyl}-3-azetidinol maleate], attenuates amyloid-β-induced neurotoxicity and promotes neurite outgrowth in rat cultured central nervous system neurons. J Pharmacol Exp Ther 314:252-259.
15. Hori E, Uwano T, Tamura R, Miyake N, Nishijo H, Ono T. 2002. Effects of a novel arginine-vasopressin derivative, NC-1900, on the spatial memory impairment of rats with transient forebrain ischemia. Brain Res Cogn Brain Res 13:1-15.
16. Hsiao KA. 2001. Learning and memory in transgenic mice modeling Alzheimer's disease. Learn Mem 8:301-308.
17. Hyman BT, Van Hoesen GW, Damasio AR, Barnes CL. 1984. Alzheimer's disease: Cell-specific pathology isolates the hippocampal formation. Science 225:1168-1170.
18. Iwasaki K, Kitamura Y, Ohgami Y, Mishima K, Fujiwara M. 1996. The disruption of spatial cognition and changes in brain amino acid, monoamine and acetylcholine in rats with transient cerebral ischemia. Brain Res 709:163-172.
19. Iwasaki K, Egashira N, Hatip-Al-Khatib I, Akiyoshi Y, Arai T, Takagaki Y, Watanabe T, Mishima K, Fujiwara M. 2006. Cerebral ischemia combined with β-amyloid impairs spatial memory in the eight-arm radial maze task in rats. Brain Res 1097:216-223.
20. Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, Ihata Y. 1994. Visualization of A β 42(43) and A β 40 in senile plaques with end-specific A β monoclonals: Evidence that an initially deposited species is A β 42(43). Neuron 13:45-53.
21. Iwatsubo T, Mann DM, Odaka A, Suzuki N, Ihara Y. 1995. Amyloid β protein (A β) deposition: A β 42(43) precedes A β 40 in Down syndrome. Ann Neurol 37:294-299.
22. Jacobsen JS, Wu CC, Redwine JM, Comery TA, Arias R, Bowlby M, Martone R, Morrison JH, Pangalos MN, Reinhart PH, Bloom FE. 2006. Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease. Neuroscience 103:5161-5166.
23. Jaspers RM, Block F, Heim C, Sontag KH. 1990. Spatial learning is affected by transient occlusion of common carotid arteries (2VO): Comparison of behavioural and histopathological changes after '2VO' and 'four-vessel- occlusion' in rats. Neurosci Lett 117:149-153.
24. Jeltsch H, Bertrand F, Lazarus C, Cassel JC. 2001. Cognitive performances and locomotor activity following dentate granule cell damage in rats: Role of lesion extent and type of memory tested. Neurobiol Learn Mem 76:81-105.
25. Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, Multhaup G, Beyreuther K, Muller H. 1987. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325:733-736.
26. Kimura M, Komatsu H, Ogura H, Sawada K. 2005. Comparison of donepezil and memantine for protective efffect against amyloid-β (1-42) toxicity in rat septal neurons. Neurosci Lett 391:17-21.
27. Kirino T. 1982. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res 239:57-69.
28. Kobayashi T, Nishijo H, Fukuda M, Bures J, Ono T. 1997. Task dependent representations in rat hippocampal place neurons. J Physiol 78:597-613.
29. Kurimoto H, Nishijo H, Uwano T, Yamaguchi H, Zhong YM, Kawanishi K, Ono T. 2004. Effects of nonsaponin fraction of red ginseng on learning deficits in aged rats. Physiol Behav 82:345-355.
30. Marchbanks RM. 1982. Biochemistry of Alzheimer's dementia. J Neurochem 39:9-15.
31. McNaughton BL, Barnes CA, Meltzer J, Sutherland RJ. 1989. Hippocampal granule cells are necessary for normal spatial learning but not for spatially-selective pyramidal cell discharge. Exp Brain Res 76:485-496.
32. Meunier J, Ieni J, Maurice T. 2006. The anti-amnesic and neuroprotective effects of donepezil against amyloid β (25-35) peptide-induced toxicity in mice involve an interaction with the sigma(1) receptor. Br J Pharmacol 149:998-1012.
33. Mignini F, Vitaioli L, Sabbatini M, Tomassoni D, Amenta F. 2004. The cerebral cortex of spontaneously hypertensive rats: A quantitative microanatomical study. Clin Exp Hypertens 26:287-303.
34. Miguel-Hidalgo JJ, Cacabelos R. 1998. β-amyloid (1-40)-induced neurodegeneration in the rat hippocampal neurons of the CA1 subfield. Acta Neuropathol 95:455-465.
35. Miguel-Hidalgo JJ, Alvarez XA, Cacabelos R, Quack G. 2002. Neuroprotection by memantine against neurodegeneration induced by β-amyloid (1-40). Brain Res 958:210-221.
36. Morris RG, Garrud P, Rawlins JN, O'Keefe J. 1982. Place navigation impaired in rats with hippocampal lesions. Nature 297:681-683.
37. Nabeshima T, Nitta A. 1994. Memory impairment and neuronal dysFunction induced by β-amyloid protein in rats. Tohoku J Exp Pharmacol 174:24-29.
38. Nakada Y, Tamura R, Kuriwaki JI, Kimura T, Uwano T, Nishijo H, Ono T. 2001. Ameliorative effects of a cognitive inhancer, T-588, on place learning impairment induced by transient forebrain ischemia in rats. Physiol Behav 74:227-235.
39. Nishijo H, Kuze S, Ono T, Tabuchi E, Endo S, Kogure K. 1992. Calcium entry blocker ameliorates ischemic neuronal damage in monkey hippocampus. Brain Res Bull 29:519-524.
40. Nishijo H, Tabuchi E, Ono T, Fukuda M, Kuze S, Endo S. 1995. Physiological results of monkey brain ischemia, and protection by a calcium blocker. Brain Res Bull 37:89-101.
41. Nitta A, Itoh A, Hasegawa T, Nabeshima T. 1994. b-Amyloid protein-induced Alzheimer's disease animal model. Neurosci Lett 170:63-66.
42. Nitta A, Fukuta T, Hasegawa T, Nabeshima T. 1997. Continuous infusion of b-Amyloid protein into the rat cerebral ventricle induces learning impairment and neuronal and morphological degeneration. Jpn J Pharmacol 73:51-57.
43. Nunn JA, LePeillet E, Netto CA, Hodges H, Gray JA, Meldrum BS. 1994. Global ischaemia: Hippocampal pathology and spatial deficits in the water maze. Brain Res 62:41-54.
44. Ogura H, Kosasa T, Kuriya Y, Yamanishi Y. 2000. Donepezil, a centrally acting acetylcholinesterase inhibitor, alleviates learning deficits in hypocholinergic models in rats. Methods Find Exp Clin Pharmacol 22:89-95.
45. Ott BR, Saver JL. 1993. Unilateral amnesic stroke. Six new cases and a review of the literature. Stroke 24:1033-1042.
46. Paxinos G, Watson C. 1986. The Rat Brain in the Stereotaxic Coordinates. New York: Academic Press.
47. Petito CK, Feldmann E, Pulsinelli WA, Plum F. 1987. Delayed hippocampal damage in humans following cardiorespiratory arrest. Neurology 37:1281-1286.
48. Pulsinelli WA, Brierley JB, Plum F. 1982. Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann Neurol 11:491-498.
49. Racchi M, Govoni S. 2003. The pharmacology of amyloid precursor protein processing. Exp Gerontol 38:145-157.
50. Redwine JM, Kosofsky B, Jacobs RE, Games D, Reilly JF, Morrison JH, Young WG, Bloom FE. 2003. Dentate gyrus volume is reduced before onset of plaque formation in PDAPP mice: A magnetic resonance microscopy and stereologic analysis. Neurosci 100:1381-1386.
51. Reilly JF, Games D, Rydel RE, Freedman S, Schenk D, Young WG, Morrison JH, Bloom FE. 2003. Amyloid deposition in the hippocampus and entorhinal cortex: Quantitative analysis of a transgenic mouse model. Neuroscience 100:4837-4842.
52. Selkoe DJ. 1998. The cell biology of b-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol 8:447-453.
53. Shin RW, Ogino K, Kondo A, Saido TC, Trojanowski JQ, Kitamoto T, Tateishi J. 1997. Amyloid β-protein (Aβ) 1-40 but not Aβ 1-42 contributes to the experimental formation of Alzheimer disease amyloid fibrils in rat brain. J Neurosci 17:8187-8193.
54. Stephan A, Laroche S, Davis S. 2001. Generation of aggregated β-amyloid in the rat hippocampus impairs synaptic transmission and plasticity and causes memory deficits. J Neurosci 21:5703-5714.
55. Stoelzel CR, Stavnezer AJ, Denenberg VH, Ward M, Markus EJ. 2002. The effects of aging and dorsal hippocampal lesions: Performance on spatial and nonspatial comparable versions of the water maze. Neurobiol Learn Mem 78:217-233.
56. Suh YH, Cheler F. 2002. Amyloid precursor protein, presenilins, and α-synuclein: Molecular pathogenesis and pharmacological applications in Alzheimer's disease. Pharmacol Rev 54:469-525.
57. Tabuchi E, Endo S, Ono T, Nishijo H, Kuze S, Kogure K. 1992. Hippocampal neuronal damage after transient forebrain ischemia in monkeys. Brain Res Bull 29:685-690.
58. Tabuchi E, Ono T, Nishijo H, Endo S, Kuzec S. 1995. Ischemic neuronal damage specific to monkey hippocampus: Histological investigation. Brain Res Bull 37:73-87.
59. Takada Y, Yonezawa A, Kume T, Katsuki H, Kaneko S, Sugimoto H, Akaike A. 2003. Nicotinic acetylcholine receptor-mediated neuroprotection by donepezil against glutamate neurotoxicity in rat cortical neurons. J Pharmacol Exp Ther 306:772-777.
60. Tamura R, Nakada Y, Nishijo H, Miyake N, Ono T. 2001. Ameliorative effects of tamolarizine on place learning impairment induced by transient forebrain ischemia in rats. Brain Res 853:81-92.
61. Tohda C, Tamura T, Komatsu K. 2003. Repair of amyloid β (25-35)-induced memory impairment and synaptic loss by a Kampo Formula, Zokumei-to. Brain Res 990:141-147.
62. Trejo JL, Carro E, Torres-Aleman I. 2001. Circulating insulin-like growth Factor I mediates exercise-induced increases in the number of new neurons in the adult hippocampus. J Neurosci 21:1628-1634.
63. Varadarajan S, Yatin S, Aksenova M, Butterfield DA. 2000. Review: Alzheimer's amyloid β-peptide-associated free radical oxidative stress and neurotoxicity. J Struct Biol 130:184-208.
64. Venters HD. 2001. Tumor necrosis factorα and insulin-like growth Factor-I in the brain: Is the whole greater than the sum of its parts? J Neuroimmunol 119:151-165.
65. Volpe BT, Holtzman JD, Hirst W. 1986. Further characterization of patients with amnesia after cardiac arrest: Preserved recognition memory. Neurology 36:408-411.
66. Ward MT, Oler JA, Markus EJ. 1999. Hippocampal dysfunction during aging. I. Deficits in memory consolidation. Neurobiol Aging 20:363-372.
67. Xavier GF, Oliveira-Filho FJ, Santos AM. 1999. Dentate gyrus-selective colchicine lesion and disruption of performance in spatial tasks: Difficulties in "place strategy" because of a lack of flexibility in the use of environmental cues? Hippocampus 9:668-681.
68. Yamada K, Nabeshima T. 2000. Animal models of Alzheimer's disease and evaluation of anti-dementia drugs. Pharmacol Ther 88:93-113.
69. Yamada K, Tanaka T, Senzakia K, Kameyama T, Nabeshima T. 1998. Propentofylline improves learning and memory deficits in rats induced by β-amyloid protein-(1-40). Eur J Pharmacol 349:15-22.
70. Yamada K, Tanaka T, Han D, Senzaki K, Kameyama T, Nabeshima T. 1999a. Protective effects of idebenone and α-tocopherol on b-amyloid (1-42)-induced learning and memory deficits in rats: Implication of oxidative stress in β-amyloid-induced neurotoxicity in vivo. Eur J Neurosci 11:83-90.
71. Yamada K, Tanaka T, Zou LB, Senzaki K, Yano K, Osada T, Olariu A, Ren X, Kameyama T, Nabeshima T. 1999b. Long-term deprivation of oestrogens by ovariectomy potentiates b-amyloid-induced working memory deficits in rats. Br J Pharmacol 128:419-427.
72. 2 and calpain responses prior to delayed neuronal death in monkeys. Eur J Neurosci 8:1932-1944.
73. Yamada K, Takayanagi M, Kamei H, Nagai T, Dohniwa M, Kobayashi K, Yoshida S, Ohhara T, Takuma K, Nabeshima T. 2005. Effects of memantine and donepezil on amyloid β-induced memory impairment in a delayed-matching to position task in rats. Behav Brain Res 162:191-199.
74. Zhong YM, Nishijo H, Uwano T, Tamura R, Kawanishi K, Ono T. 2000. Red ginseng ameliorated place navigation deficits in young rats with hippocampal lesions and aged rats. Physiol Behav 69:511-525.
75. Zola-Morgan S, Squire LR, Amaral DG. 1986. Human amnesia and the medial temporal region: Enduring memory impairment following a bilateral lesion limited to field CA1 of the hippocampus. J Neurosci 6:2950-2967.
76. Zola-Morgan S, Squire LR, Rempel NL, Glower RP, Amaral DG. 1992. Enduring memory impairment in monkeys after ischemic damage to the hippocampus. J Neurosci 12:2582-2596.